Non-Hodgkin Lymphoma
Showing NaN - NaN of 22
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ
Recruiting
- Acute Lymphoblastic Leukemia, Adult B-Cell
- +3 more
- clonoSEQ Assay
-
Stanford, California
- +15 more
Jan 30, 2023
Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255
Recruiting
- Non-Hodgkin Lymphoma
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NKTR-255 at 1.5 µg/kg
- +3 more
-
La Jolla, California
- +26 more
Jan 10, 2023
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,
Active, not recruiting
- Acute Biphenotypic Leukemia
- +18 more
- Cyclophosphamide
- +8 more
-
Aurora, Colorado
- +2 more
Dec 28, 2022
Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene
Active, not recruiting
- Non-Hodgkin Lymphoma
- +4 more
- JCAR017 (lisocabtagene maraleucel) single-dose schedule
- JCAR017 (lisocabtagene maraleucel) 2-dose schedule
-
Birmingham, Alabama
- +24 more
Nov 21, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)
Recruiting
- B-cell Malignancy
- +3 more
- CTX110
-
Los Angeles, California
- +27 more
May 6, 2022
Collecting and Storing Tissue Samples From Rare or Cutaneous
Active, not recruiting
- Adult Immunoblastic Lymphoma
- +12 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +129 more
Mar 23, 2022
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)
Completed
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
-
Tucson, Arizona
- +9 more
Feb 10, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin,
Completed
- Anaplastic Large-Cell Lymphoma
- +2 more
- brentuximab vedotin
- +4 more
-
Gilbert, Arizona
- +143 more
Nov 1, 2021
Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell
Completed
- Adult Diffuse Large B-Cell Lymphoma
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Salt Lake City, Seattle, Torino
Completed
- Acute Lymphoblastic Leukemia
- +9 more
- Cyclosporine
- +3 more
-
Salt Lake City, Utah
- +4 more
Jan 15, 2020
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia Trial in
Completed
- Aggressive Non-Hodgkin Lymphoma
- +20 more
- Atorvastatin Calcium
- +7 more
-
Denver, Colorado
- +1 more
Dec 26, 2019
Non-Hodgkin Lymphoma Trial in Seattle (drug, biological, procedure)
Completed
- Non-Hodgkin Lymphoma
- Carboplatin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 28, 2017
Haploidentical Graft Recipients
Completed
- Leukemia
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Mar 9, 2015